Forward P/S Multiple: BrainsWay Limited (BWAY)

Corporate emblem and logo of brainsway.com (BWAY)

The expected revenue multiple visualizes the speed of revenue revaluation for BrainsWay Ltd. (BWAY), with 3.20 indicating the current level. The asset serves as a defensive tool due to its independence from macroeconomic factors. However, resilience is limited by insurance coverage complexities and competition from pharmaceuticals. The operational stability of TMS systems also depends on adherence to strict high-tech transportation regulations for delivering equipment to medical centers.

BWAY (BrainsWay Limited) Market Cap to Future Revenue Ratio history from 07/04/2022 to 11/13/2026

brainsway.com (BWAY) - metric breakdowns and financial figures

- stock price and consensus target price:
Stock Quotes BrainsWay|BWAY - Consensus Target
- company stock exchange capitalization indicators:
Market Capitalization BrainsWay Ltd.|BWAY - Enterprise Value
- issuer book value statistics:
Accounting Value per Share BrainsWay|BWAY - Total Stockholders' Equity|Market Cap to Net Assets Ratio brainsway.com|BWAY - Aggregate Asset Value
- issuer credit burden and liquidity indicators:
Debt to Equity BrainsWay Ltd.|BWAY - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio BrainsWay|BWAY - Company Cumulative Indebtedness|Debts to Book Capitalization BrainsWay Ltd.|BWAY - Company Long-Term Indebtedness|Company Current Liabilities BrainsWay|Quick Ratio brainsway.com
- net income and valuation multiples indicators:
BWAY - Company Net Income|Future Profit BrainsWay Ltd.|BWAY - Price to Earnings Ratio|Forward P/E Multiple BrainsWay|BWAY - PEG Multiple|Enterprise Value to EBITDA Ratio BrainsWay Ltd.|BWAY - Profit before interest, taxes and amortization|Earnings per share for the last twelve months BrainsWay|BWAY - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months brainsway.com|BWAY - Expected net earnings per share growth this year|Expected earnings per share growth for next year BrainsWay Ltd.
- revenue and sales details:
BWAY - Company Total Revenue|Projected Sales Volume BrainsWay|BWAY - Market Cap to Revenue|Forward P/S Multiple BrainsWay Ltd.
General company analysis:BrainsWay Limited BWAY
Original product of BrainsWay Ltd

The forward P/S ratio relates current market capitalization to expected revenue for the coming year, allowing for an assessment of the degree of investor optimism priced in. By analyzing the forward P/S trajectory, one can determine the extent to which the market overvalues the potential of BrainsWay Ltd. (BWAY) magnetic brain stimulation technology in treating depression, in order to timely recognize the risk of a correction should sales forecasts remain unmet.

Competitor analysis for BrainsWay Ltd.

Acadia Healthcare Company, Inc. - Forward Price-to-Revenue Multiple|LFST - Forward Price-to-Revenue Multiple|Nexalin - Forward P/S Multiple